381 Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals
Autor: | Piros, É.A., Cseprekál, O., Lukács, A., Hidvégi, B., Medvecz, M., Szabó, Z., Barabás, E., Galajda, N., Miheller, P., Holló, P. |
---|---|
Zdroj: | In Journal of Investigative Dermatology December 2022 142(12) Supplement:S246-S246 |
Databáze: | ScienceDirect |
Externí odkaz: |